Ezetrol

Ezetimibe (Ezetrol) is a branded cholesterol-lowering medicine containing ezetimibe 10 mg, a selective inhibitor of intestinal cholesterol absorption. Ezetrol is the original branded formulation of ezetimibe and has been extensively studied in clinical trials, providing robust evidence for its safety and efficacy in reducing LDL cholesterol. It is used both as a standalone treatment and in combination with statin therapy as part of a comprehensive approach to cardiovascular risk management.

Mechanism of Action

Ezetrol works at the brush border of the small intestine, where it targets and inhibits the Niemann-Pick C1-Like 1 (NPC1L1) protein — the primary transporter responsible for absorbing cholesterol from the digestive tract into the bloodstream. This is a distinctly different mechanism from statins, which reduce cholesterol synthesis in the liver. By reducing intestinal cholesterol absorption, Ezetrol lowers the amount of cholesterol reaching the liver, prompting the liver to increase its expression of LDL receptors and clear more LDL cholesterol from the circulation. As monotherapy, Ezetrol reduces LDL cholesterol by around 15 to 22%, and the effect is additive when combined with a statin.

Who Benefits from Ezetrol?

Ezetrol is prescribed for adults with primary hypercholesterolaemia or mixed dyslipidaemia who require additional LDL reduction beyond what dietary measures and statin therapy alone can achieve. It is also an option for patients who cannot tolerate statins and need an alternative lipid-lowering agent. For patients with homozygous familial hypercholesterolaemia — an inherited condition causing severely elevated cholesterol from birth — Ezetrol is used alongside other treatments to achieve meaningful LDL reduction.

Practical Use

Ezetrol is taken once daily as a single 10 mg tablet. It may be taken at any time of day, with or without food, making it easy to incorporate into a daily routine. No dose adjustment is needed for the elderly or patients with renal impairment. It should be taken at least two hours before or four hours after bile acid sequestrants.

How to Take Ezetrol

Take Ezetrol (ezetimibe 10 mg) once daily, at any time of day, with or without food. Take it at the same time each day to build a consistent routine. It can be taken at the same time as a statin, or separately — there is no need to co-administer them.

Ezetrol works by reducing the absorption of cholesterol from the gut. When used alongside a statin, it provides an additional 15 to 20% reduction in LDL cholesterol on top of what the statin achieves alone. For patients who cannot tolerate statins, Ezetrol as monotherapy lowers LDL by around 15 to 22%.

Diet Matters Too

Ezetrol is most effective as part of a broader strategy that includes a heart-healthy diet. Do not stop Ezetrol without speaking to your doctor — the cholesterol benefit disappears within weeks of stopping.

The dose of Ezetrol is fixed at 10 mg once daily for all adult patients. No dose adjustment is required for the elderly, and the dose does not vary according to the degree of hypercholesterolaemia. Ezetrol may be taken at any time of day, with or without food.

No dose adjustment is required in patients with mild hepatic impairment. Ezetrol is not recommended in moderate to severe hepatic impairment (Child-Pugh B or C), particularly in combination with statins, as ezetimibe exposure is significantly increased in this setting. In patients with renal impairment of any degree of severity, no dose adjustment is necessary.

If Ezetrol is prescribed in combination with a bile acid sequestrant such as colestyramine, it should be taken either two hours before or four hours after the sequestrant to ensure adequate absorption. Lipid levels should be checked before starting therapy and at regular intervals — typically at six to twelve weeks after initiation or any dose change — to assess the treatment response and guide ongoing management.

Common Side Effects

Ezetrol is generally very well tolerated. Side effects reported in clinical trials include:

• Headache
• Abdominal pain or discomfort
• Diarrhoea
• Flatulence
• Fatigue
• Nasopharyngitis (cold-like symptoms)

Gastrointestinal symptoms are the most commonly reported and are usually mild and short-lived.

Muscle Effects When Combined with a Statin

When Ezetrol is taken alongside a statin, both medicines can contribute to muscle-related effects. Tell your doctor if you develop unexplained muscle pain, weakness, or tenderness — this may need to be investigated with blood tests. Liver function abnormalities have been reported rarely, particularly with combination therapy.

Muscle Safety

When Ezetrol is used in combination with a statin, the risk of muscle-related adverse effects is increased relative to statin monotherapy. All patients should be counselled to report any unexplained muscle pain, weakness, or cramps without delay. If myopathy is suspected, creatine kinase should be measured and Ezetrol plus statin discontinued if levels are markedly elevated or if clinical myopathy is confirmed. Risk factors for myopathy include advanced age, renal impairment, and hypothyroidism.

Liver Function Monitoring

Liver function tests are recommended before initiating combination therapy with Ezetrol and a statin, and periodically during treatment in accordance with statin prescribing guidelines. Ezetrol itself has been associated with isolated transaminase elevations. In the event of clinically significant or persistent liver enzyme abnormalities, treatment should be reviewed and alternative causes investigated.

Fibrate Combination

Combining Ezetrol with a fibrate is not generally recommended and is not licensed in the UK without specific clinical justification. Fenofibrate combination is less problematic than gemfibrozil; the latter can increase ezetimibe plasma exposure substantially. If a fibrate is considered essential alongside Ezetrol, the combination should be carefully supervised with monitoring for cholelithiasis, as fibrates increase cholesterol excretion into bile.

Ezetrol (ezetimibe) must not be used in patients who:

• Have a known hypersensitivity to ezetimibe or any of the tablet excipients
• Have moderate or severe hepatic impairment, particularly when prescribed alongside a statin
• Have active liver disease or persistent, unexplained elevations in serum transaminases (when co-prescribed with a statin)
• Are pregnant — especially in combination with statins, which are absolutely contraindicated in pregnancy
• Are breastfeeding — there are insufficient safety data to support use in nursing mothers
• Are children under 6 years of age — safety and efficacy have not been established in this age group